Citi raised the firm’s price target on Intuitive Surgical (ISRG) to $650 from $590 and keeps a Buy rating on the shares. The firm updated models in medical technology following the Q1 reports. The good news is that underlying sector fundamentals appear intact, including volumes, pricing, and capex, the analyst tells investors in a research note.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical call volume above normal and directionally bullish
- Baird says CEO ‘well-equipped’ to further Intuitive Surgical position
- Intuitive Surgical Appoints David Rosa as CEO
- Intuitive Surgical announces promotion of Dave Rosa to CEO
- Wolfpack Research says short UFP Technologies, growth story ‘in shambles’